文献速递眼底病与葡萄膜炎

增殖性糖尿病视网膜病变中的人玻璃体:特征与转化意义

Human vitreous in proliferative diabetic retinopathy: Characterization and translational implications.
PubMed 文献 · Prog Retin Eye Res · 2019-04-02

本文综述糖尿病视网膜病变(DR)进展至增殖性糖尿病视网膜病变(PDR)过程中玻璃体的结构与分子改变,指出玻璃体改变反映视网膜及玻璃体视网膜界面的病理事件,并可反过来作用于糖尿病视网膜形成恶性循环;同时讨论利用玻璃体在体外、离体和体内模型研究PDR发病机制及作为新药临床前评价工具的转化意义。

要点

  • DR由长期高血糖介导的视网膜病理改变累积所致,可从无症状视网膜异常进展为以新生血管或视网膜前/玻璃体出血为特征的PDR。
  • DR进展中玻璃体的结构与分子改变是视网膜组织代谢与功能改变的结果,反映玻璃体视网膜界面发生的病理事件。
  • PDR玻璃体是病理信号分子的储库,可在体外、离体和体内模型中用于研究PDR发病机制并支持新药临床前评价。

核心结论

  • 玻璃体的结构与分子改变反映糖尿病视网膜病变进展中玻璃体视网膜界面的病理事件,PDR玻璃体可对糖尿病视网膜产生病理作用并参与形成促进疾病进展的恶性循环。
  • 研究PDR玻璃体在不同体外、离体和体内实验模型中的生物学活性可为PDR发病机制提供见解,PDR患者玻璃体可作为获取新药临床前实验证据的新工具。

研究设计与样本

  • 综述,总结DR/PDR的主要病理特征并聚焦DR及进展至PDR过程中玻璃体结构与组成改变。
  • 综述讨论利用不同体外、离体和体内实验模型研究玻璃体生物学活性以探讨PDR发病机制。

主要发现

  • DR始于无症状视网膜异常,可进展为以新生血管或视网膜前/玻璃体出血为特征的PDR。
  • 玻璃体为填充眼后腔的透明凝胶,对维持眼功能起重要作用。
  • DR进展中玻璃体的结构与分子改变由视网膜组织代谢与功能改变所致。
  • 这些玻璃体改变由糖尿病中的缺氧、氧化、炎症、神经退行性和白细胞淤滞状态引起。
  • PDR玻璃体是病理信号分子的储库。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Diabetic retinopathy (DR) is one of the leading causes of visual impairment in the working-age population. DR is a progressive eye disease caused by long-term accumulation of hyperglycaemia-mediated pathological alterations in the retina of diabetic patients. DR begins with asymptomatic retinal abnormalities and may progress to advanced-stage proliferative diabetic retinopathy (PDR), characterized by neovascularization or preretinal/vitreous haemorrhages. The vitreous, a transparent gel that fills the posterior cavity of the eye, plays a vital role in maintaining ocular function. Structural and molecular alterations of the vitreous, observed during DR progression, are consequences of metabolic and functional modifications of the retinal tissue. Thus, vitreal alterations reflect the pathological events occurring at the vitreoretinal interface. These events are caused by hypoxic, oxidative, inflammatory, neurodegenerative, and leukostatic conditions that occur during diabetes. Conversely, PDR vitreous can exert pathological effects on the diabetic retina, resulting in activation of a vicious cycle that contributes to disease progression. In this review, we recapitulate the major pathological features of DR/PDR, and focus on the structural and molecular changes that characterize the vitreal structure and composition during DR and progression to PDR. In PDR, vitreous represents a reservoir of pathological signalling molecules. Therefore, in this review we discuss how studying the biological activity of the vitreous in different in vitro, ex vivo, and in vivo experimental models can provide insights into the pathogenesis of PDR. In addition, the vitreous from PDR patients can represent a novel tool to obtain preclinical experimental evidences for the development and characterization of new therapeutic drug candidates for PDR therapy.

来源:Prog Retin Eye Res,查看原文。版权归原作者所有。

引用

  1. Nawaz IM, Rezzola S, Cancarini A, et al. Human vitreous in proliferative diabetic retinopathy: Characterization and translational implications. Prog Retin Eye Res. 2019. PMID: 30951889. doi:10.1016/j.preteyeres.2019.03.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。